The buying interest on the pharma company's counter came after it launched 'Wanbury C RED', a Liposomal Iron formulation ...

LONDON, GREATER LONDON, UNITED KINGDOM, June 18, 2025 /EINPresswire / -- The Business Research Company's Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts ...

A post-hoc analysis of the phase 3b JUMP trial assessed outcomes in patients with myelofibrosis and baseline anemia who were treated with ruxolitinib alongside anemia-supportive therapies, according ...

Among the 7MM, Japan accounts for the second highest total aplastic anemia drugs market. The Aplastic Anemia Treatment Market Size in Japan has been assessed to be ~USD 35 million in 2023, expected to ...

Akebia Therapeutics, Inc. (NASDAQ:AKBA) is one of the 10 best healthcare penny stocks to buy according to analysts.

A nne Romatowski noticed a small, soft something in the flesh below her collarbone just before Christmas. She wasn’t ...

During a live event, Thomas LeBlanc, MD, MA, discussed the outcomes of the COMMANDS trial of luspatercept in myelodysplastic ...

Anemia commonly occurs in people with HIV. Learn about what causes anemia, how to treat it, and more.

A post-hoc analysis of the phase 3b JUMP trial found that ruxolitinib plus anemia supportive care maintained efficacy and reduced transfusion needs in patients with myelofibrosis.

Anemia is usually mild, and a person can typically receive effective treatment. However, some types of anemia are severe and potentially life threatening.

Panelists discuss how to approach a 67-year-old man with advanced polycythemia vera who is resistant to hydroxyurea, ...

An overview of World Sickle Cell Anemia Day 2025 and the global and local challenges of managing sickle cell disease.